← Back to Search

Procedure

Sphenopalatine Ganglion Block for Post-Dural Puncture Headache

Phase 3
Waitlist Available
Led By William Grubb, DDS, MD
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up prior to initiation of therapy (epidural blood patch vs sphenopalatine ganglion block).
Awards & highlights

Study Summary

This trial will compare a pain block in the midface to the traditional, more invasive, therapeutic epidural patch for the treatment of headaches.

Eligible Conditions
  • Post-Dural Puncture Headache

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 60 minutes following either therapy.
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 60 minutes following either therapy. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Headaches With a VAS Score >8/10 Prior to Initiation of Either Therapy
Number of Participants With a Headache Vas 8/10 at 30 Minutes Following Either Therapy.
Number of Participants With a Headache Vas 8/10 at 60 Minutes Following Either Therapy.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Sphenopalatine Ganglion BlockExperimental Treatment1 Intervention
Cotton tip applicators are used to deliver lidocaine to the posterior nares in the area of skin overlying the Sphenopalatine gangion
Group II: Epidural blood patchActive Control1 Intervention
20ml of sterile blood is obtained from the patients arm and placed in the epidural space using standard sterile epidural access.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sphenopalatine Ganglion Block
2023
N/A
~50

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,224 Total Patients Enrolled
New Jersey Medical SchoolOTHER
7 Previous Clinical Trials
11,122 Total Patients Enrolled
William Grubb, DDS, MDPrincipal InvestigatorRutgers Robert Wood Johnson Medical School
1 Previous Clinical Trials
8 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025